BioCorRx Inc.
BICX
$0.44
$0.0410.25%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4,355.00% | 3,647.22% | -100.00% | -- | -79.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4,355.00% | 3,647.22% | -100.00% | -- | -79.59% |
| Cost of Revenue | -- | -- | -100.00% | -- | -- |
| Gross Profit | 4,355.00% | 6,645.00% | -100.00% | -- | -56.99% |
| SG&A Expenses | 47.33% | 18.13% | 20.99% | 76.86% | 16.78% |
| Depreciation & Amortization | 974.63% | 270.15% | 94.03% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.93% | 10.34% | 33.62% | 70.75% | 42.10% |
| Operating Income | -3.25% | 3.18% | -36.71% | -72.54% | -44.62% |
| Income Before Tax | -11.61% | 31.17% | -26.69% | -74.45% | -33.62% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.61% | 31.17% | -26.69% | -74.45% | -33.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 761.68% | 1,385.71% | 12,500.00% | 2,227.27% | 1,418.18% |
| Net Income | -1.32% | 31.97% | -20.25% | -71.70% | -31.97% |
| EBIT | -3.25% | 3.18% | -36.71% | -72.54% | -44.62% |
| EBITDA | 1.52% | 5.08% | -36.24% | -73.05% | -44.93% |
| EPS Basic | 43.67% | 60.55% | 18.43% | -34.38% | -18.07% |
| Normalized Basic EPS | 49.75% | 66.67% | 23.93% | -21.92% | -21.83% |
| EPS Diluted | 43.67% | 60.55% | 18.43% | -34.38% | -17.00% |
| Normalized Diluted EPS | 49.75% | 66.67% | 23.93% | -21.92% | -21.83% |
| Average Basic Shares Outstanding | 79.84% | 72.36% | 47.48% | 27.77% | 11.76% |
| Average Diluted Shares Outstanding | 79.84% | 72.36% | 47.48% | 27.77% | 11.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |